Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Curevac N.V. (NQ: CVAC )

113.00 +3.71 (+3.39%)
Official Closing Price Updated: 7:59 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,790,500
Open 110.25
Bid (Size) 113.05 (2)
Ask (Size) 114.00 (1)
Prev. Close 109.29
Today's Range 109.02 - 113.00
52wk Range 36.15 - 151.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
From ACCESSWIRE
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
From ACCESSWIRE

Performance

YTD
+32.78%
+32.78%
1 Month
+19.84%
+19.84%
3 Month
+9.46%
+9.46%
6 Month
+111.21%
+111.21%
1 Year
+102.15%
+102.15%

More News

Read More
4 Top Biotech Stocks To Watch In The Stock Market Today
Tags Market News
From StockMarket.com
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
From ACCESSWIRE
7 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags PFE Benzinga CVAC
From Benzinga
Why PPD, Immunic, Inovio and CureVac Shares Are Higher Today
Tags Market News TMO Small Cap
From Benzinga
Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine
Tags CH:NOVN MRK NVS
From MarketWatch
CureVac (CVAC) Q4 2020 Earnings Call Transcript
Tags Market News CVAC
From Motley Fool
CureVac says it is on track with COVID-19 vaccine as it posts earnings update
Tags CVAC CH:NOVN
From MarketWatch
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
Tags MRNA PFE Benzinga
From Benzinga
South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
Tags News GSK MRK
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.